Why is endotoxin testing separate from a sterility test?

I have a logging thermometer, a box of insulin syringes and no illusions about my worktop being sterile.

I can predict the outcome but I cannot explain it, which means I will get the next case wrong.

I would like to know how confident the field actually is about this.

What is actually going on here, physically?

Stated carefully, the response is dose-dependent and systemic — fever, chills, malaise — rather than local.

Certificates that report endotoxin do so in EU per milligram of peptide. To convert to a dose exposure, multiply by the milligrams administered — which is why a low figure per milligram can still matter at a high dose.

Specifically, a 0.22 micrometre filter does not retain endotoxin; the molecule passes through freely and can form aggregates that are still far smaller than the pore. Removing it requires ultrafiltration, ion exchange or affinity chromatography.

Endotoxin thermal stability well above autoclave temperatures is documented and is the reason dry-heat depyrogenation exists as a separate process.

Filtration does not remove it. Autoclaving does not destroy it. Only specific processes do.

The relevant point is that a preparation can be sterile and still pyrogenic, which is not a paradox once you know what the molecule is.

The limulus amoebocyte lysate assay is the standard quantitative test, in gel-clot, turbidimetric and chromogenic formats, with results reported in endotoxin units. A recombinant factor C assay is the modern animal-free alternative.

Symptoms of a pyrogenic reaction are systemic and appear within a few hours: fever, rigors, headache and malaise, without local signs at the injection site.

The 5 EU/kg/hour parenteral limit is the standard pharmacopoeial threshold for non-intrathecal administration and is the basis for product-specific limits.

Sterility and pyrogenicity are different tests. Passing one says nothing about the other.

To be exact about it, depyrogenation requires dry heat at around 250 degrees Celsius or a specific chemical process, neither of which applies to a peptide.

Water is the usual route of contamination, since Gram-negative organisms grow readily in it and leave endotoxin behind after they die. Water for injection is manufactured to a specific endotoxin limit for exactly that reason.

Water for injection carries a specified endotoxin limit precisely because water systems are the dominant contamination route in parenteral manufacturing.

Nobody at this tier reports it. Treat the absence as the category norm and price it in.

Answer first: endotoxin is lipopolysaccharide from Gram-negative cell walls, it is heat-stable, and it survives every sterilisation process that kills the organism that produced it.

Depyrogenation of glassware is done by dry heat, conventionally 250 degrees for thirty minutes or equivalent. This is why pharmaceutical vials are depyrogenated before filling and why household equipment is not.

The general principle here — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science, and it is why licensed presentations contain a surfactant such as polysorbate 20 or 80. A research vial does not, which is precisely why handling matters more, not less.

The caveat is that no research-grade certificate this community has seen reports endotoxin, so its status in any given vial is simply unknown.

5 EU/kg/hour is the parenteral limit worth knowing.

edited 30 Jul 2024 by fresh_bac — added a caveat about sampling